Hanan Aati | Medicinal Chemistry | Editorial Board Member

Editorial Board Member

Hanan Aati
King Saud University, Saudi Arabia

Hanan Aati
Affiliation King Saud University
Country Saudi Arabia
Scopus ID 57203870584
Documents 65
Citations 1,061
h-index 20
Subject Area Medicinal Chemistry
Event International Chemistry Scientist Awards
ORCID 0000-0003-1598-2273

Hanan Aati is a researcher affiliated with King Saud University, Saudi Arabia, whose listed subject area is medicinal chemistry. Her bibliographic profile provides a basis for examining her scholarly publication activity and citation record in the context of pharmaceutical and chemical research. The researcher identifiers and bibliometric figures presented here are supplied profile data and should be interpreted in accordance with the information available through the linked scholarly databases. [1] [2]

Abstract

This article presents a scholarly profile of Hanan Aati, affiliated with King Saud University in Saudi Arabia and associated with the subject area of medicinal chemistry. The supplied Scopus profile data lists 65 documents, 1,061 citations, and an h-index of 20. These indicators provide a quantitative snapshot of indexed scholarly output and citation activity; they do not independently establish the quality, originality, or practical significance of individual research contributions. The article also outlines the relevance of medicinal chemistry to drug discovery and discusses the considerations involved in assessing research recognition and editorial service. [1] [2]

Keywords

Hanan Aati, medicinal chemistry, King Saud University, Saudi Arabia, pharmaceutical research, drug discovery, scholarly publications, citation analysis, Scopus, ORCID, editorial board member, International Chemistry Scientist Awards.

Introduction

Medicinal chemistry is an interdisciplinary field concerned with the design, synthesis, characterization, and evaluation of compounds with potential therapeutic applications. It draws on organic chemistry, biochemistry, pharmacology, molecular biology, and related disciplines to investigate relationships between chemical structure and biological activity. Research in this area can support the identification of candidate molecules, optimization of their properties, and development of scientific understanding relevant to therapeutic discovery. [1]

Research Profile

The profile information supplied for Hanan Aati includes an institutional affiliation with King Saud University, Saudi Arabia, and a subject classification in medicinal chemistry. The Scopus author identifier is 57203870584, while the ORCID iD is 0000-0003-1598-2273. These persistent identifiers can help readers find indexed publications, examine authorship records, and distinguish between researchers in bibliographic systems. [1] [2]

Research Contributions

Medicinal chemistry research commonly addresses the relationship between molecular structure and biological function, with the aim of understanding how chemical modifications may influence potency, selectivity, stability, solubility, and other properties relevant to candidate compounds. Research contributions in this field can include compound synthesis, molecular characterization, structure–activity relationship analysis, computational studies, and collaborative investigations of pharmacological activity. These are general features of the discipline and should not be interpreted as a list of specific projects conducted by Hanan Aati without supporting publication records. [2]

Publications

The supplied Scopus profile data records 65 documents for Hanan Aati. The linked author record is the appropriate starting point for reviewing indexed publications, co-authors, source titles, publication dates, and available citation information. [1]

Research Impact

The supplied bibliometric figures for Hanan Aati are 65 documents, 1,061 citations, and an h-index of 20. These values summarize different dimensions of indexed research activity. The document count represents the number of records attributed to the profile, the citation count reflects recorded citations, and the h-index combines publication productivity with citation frequency under a defined threshold. [1]

Award Suitability

The International Chemistry Scientist Awards provides the event context associated with this profile. The supplied bibliometric data and the stated medicinal chemistry subject area may be relevant background information when considering a researcher’s academic record. However, the presence of a profile on this page does not by itself establish nomination, selection, award receipt, or formal appointment to an editorial board.[2]

Conclusion

Hanan Aati is identified in the supplied profile data as a medicinal chemistry researcher affiliated with King Saud University in Saudi Arabia. The profile lists 65 documents, 1,061 citations, and an h-index of 20, together with Scopus and ORCID identifiers that support further bibliographic verification. These indicators offer a useful starting point for reviewing scholarly activity but should be interpreted alongside publication-level evidence and field-specific context. A more detailed account of research contributions, editorial responsibilities, or award recognition would require confirmation from primary institutional, publisher, or event sources.[2]

References

  1. Elsevier. (n.d.). Scopus author details: Hanan Aati, Author ID 57203870584. Scopus. Profile metrics reproduced from the supplied profile data; database values may change over time.
    https://www.scopus.com/authid/detail.uri?authorId=57203870584
  2. ORCID. (n.d.). ORCID profile of Hanan Aati. ORCID Registry.
    https://orcid.org/0000-0003-1598-2273

Assoc. Prof. Dr. Zubair Anwar | Phrmaceutical Chemistry | Editorial Board Member

Assoc. Prof. Dr. Zubair Anwar | Phrmaceutical Chemistry | Editorial Board Member

Deputy Director | Baqai Medical University | Pakistan

Assoc. Prof. Dr. Zubair Anwar is a leading researcher in Pharmaceutical Chemistry, recognized for his extensive contributions to drug stability, photochemistry, kinetic degradation studies, analytical method development, pharmaceutical formulations, and biopolymer-based drug-delivery systems. His research integrates experimental chemistry with computational modeling to explore photostabilization mechanisms, degradation pathways, and formulation optimization for small molecules and therapeutics. Dr. Anwar has authored 55 Scopus-indexed documents with 719 citations from 580 citing documents and holds an h-index of 12, reflecting the significant influence and continuity of his scholarly work within the pharmaceutical sciences community. His scientific outputs span advanced spectroscopic techniques, stability-indicating analytical procedures, polymeric delivery systems, periodontal drug-delivery devices, hydrogels, and cyclodextrin-assisted photostability enhancements. He has contributed to internationally indexed journals and book chapters covering drug degradation, excipient interactions, chitosan-based xerogels, periodontal implants, and computational kinetic modeling. Dr. Anwar’s recent work includes innovative biopolymer-based dental chips, PEGylated chitosan xerogels, and highly stable enzymatic hydrogels designed for wound-healing applications. His research consistently bridges fundamental pharmaceutical chemistry with applied therapeutics, leading to impactful publications, collaborative research outputs, and notable advancements in formulation science and drug-delivery technologies. In addition to publishing widely, he contributes as a peer reviewer for multiple reputable scientific journals, demonstrating his commitment to advancing quality, rigor, and innovation in pharmaceutical research. His body of work continues to influence drug-delivery design, analytical chemistry, and stability science across academia and industry.

Profiles : Scopus | Orcid

Featured Publications :

  • Afzal, S., Sheraz, M. A., Ahmed, S., Tariq, S., Kazi, S. H., Zafar, F., & Anwar, Z. (2025). Chitosan-based biodegradable dental chips impregnated with chlorhexidine gluconate for the treatment of periodontitis. RSC Pharmaceutics.

  • Khurshid, A., Anwar, Z., Usmani, M., Altaf, R., Awan, A., Akram, Z., Kazi, S. H., Ahmed, S., Sheraz, M. A., & Ahmad, I. (2025). Cyclodextrin-assisted photostabilization of 5-fluorouracil: A combined kinetic and computational investigation. RSC Advances.

  • Zafar, F., Sheraz, M. A., Ali, S. A., Riaz, M., Ahmed, S., & Anwar, Z. (2025). Novel antibiotic-loaded PEGylated xerogels of acidified chitosan for periodontal diseases. Current Drug Delivery.

  • Zia, S. Y., Ahmed, S., Jamal, H. S., Perveen, M., Sheraz, M. A., Anwar, Z., & Ali, S. A. (2025). Formulation development of highly stable collagenase-containing hydrogels for wound healing. Journal of Pharmaceutical Sciences.

  • Zafar, F., Sheraz, M. A., Ali, S. A., Riaz, M., Ahmed, S., Kazi, S. H., Tariq, S., & Anwar, Z. (2025). PEGylated chitosan xerogels for localized periodontal therapy: Design, characterization, and drug release. Scientific Reports.